Sirolimus-based immunosuppresive protocol for calcineurin sparing in liver transplantation

被引：19

作者：

Heffron, TG ^{[1
]}

Smallwood, GA

Davis, L

Martinez, E

Stieber, AC

机构：

[1] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA

[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA

[3] Emory Univ Hosp, Dept Pharm, Atlanta, GA 30322 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期

关键词：

D O I：

10.1016/S0041-1345(02)02956-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1522 / 1523

页数：2

共 5 条

[1] Experience with the use of sirolimus in liver transplantation - Use in patients for whom calcineurin inhibitors are contraindicated [J].

Chang, GJ ;

Mahanty, HD ;

Quan, D ;

Freise, CE ;

Ascher, NL ;

Roberts, JP ;

Stock, PG ;

Hirose, R .

LIVER TRANSPLANTATION, 2000, 6 (06) :734-740

[2] mTOR inhibitors: An overview [J].

Neuhaus, P ;

Klupp, J ;

Langrehr, JM .

LIVER TRANSPLANTATION, 2001, 7 (06) :473-484

[3] Liver transplantation using sirolimus and minimal corticosteroids (3-day taper) [J].

Trotter, JF ;

Wachs, M ;

Bak, T ;

Trouillot, T ;

Stolpman, N ;

Everson, GT ;

Kam, I .

LIVER TRANSPLANTATION, 2001, 7 (04) :343-351

[4]

*US MULT FK506 LIV, 1994, NEW ENGL J MED, V332, P1110

[5] Sirolimus: A potent new immunosuppressant for liver transplantation [J].

Watson, CJE ;

Friend, PJ ;

Jamieson, NV ;

Frick, TW ;

Alexander, G ;

Gimson, AE ;

Calne, R .

TRANSPLANTATION, 1999, 67 (04) :505-509

← 1 →